Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: First Quarter 2019 (ended March 31, 2019)
Filing Date: May 2, 2019
This filing serves as a cover document announcing the Company's first-quarter 2019 results. The detailed financial data and press release are provided as Exhibits 99.1 and 99.2, respectively.
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibits (99.1 and 99.2).
The Company utilizes the following non-GAAP financial measures to supplement IFRS reporting:
- EBITDA (Operating income excluding interest, taxes, depreciation, and amortization)
- Delivered operating income (Earnings before interest and taxes)
- Free cash flow
- Results presented in constant currency
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached Press Release (Exhibit 99.1) and financial figures (Exhibit 99.2) for period-over-period comparisons.
Guidance, Outlook, and Risks
Management Commentary: Management states that non-GAAP measures are included to enhance understanding of current performance and future prospects, as well as to ensure consistency with historical reporting.
Regulatory Note: The Company explicitly states that non-GAAP measures should not be used as a substitute for or considered superior to GAAP (IFRS) financial measures. Reconciliations between non-GAAP and IFRS measures are included in the attached exhibits.
Legal Status of Exhibits: The attached exhibits are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2019 revenue and profit figures.
- Examine Exhibit 99.2 for the detailed reconciliation of non-GAAP measures (EBITDA, Free Cash Flow) to IFRS standards.
- Verify constant currency adjustments to understand organic growth versus currency fluctuation impacts.
- Confirm the specific debt and liquidity positions in the attached financial statements, as they are not listed in this cover document.